347 related articles for article (PubMed ID: 11239793)
1. Direct vascular effects of HMG-CoA reductase inhibitors.
Laufs U; Liao JK
Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
[TBL] [Abstract][Full Text] [Related]
2. Statins and ischemic stroke.
Liao JK
Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
Takemoto M; Liao JK
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
[TBL] [Abstract][Full Text] [Related]
4. Statins and their role in vascular protection.
Mason JC
Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of HMG-CoA reductase inhibitors.
Werner N; Nickenig G; Laufs U
Basic Res Cardiol; 2002 Mar; 97(2):105-16. PubMed ID: 12002257
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
8. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
Liao JK
Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
[TBL] [Abstract][Full Text] [Related]
10. Influence of statin use on endothelial function: from bench to clinics.
Martínez-González J; Badimon L
Curr Pharm Des; 2007; 13(17):1771-86. PubMed ID: 17584107
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of pleiotropic effects of statins: lipid reduction and beyond.
Auer J; Berent R; Weber T; Eber B
Curr Med Chem; 2002 Oct; 9(20):1831-50. PubMed ID: 12369881
[TBL] [Abstract][Full Text] [Related]
12. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
13. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
Koh KK
Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215
[TBL] [Abstract][Full Text] [Related]
14. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
15. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
Vaughan CJ; Delanty N; Basson CT
CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
[TBL] [Abstract][Full Text] [Related]
16. The cardioprotective effects of statins.
Eto M; Lüscher TF
Coron Artery Dis; 2004 Aug; 15(5):243-5. PubMed ID: 15238819
[TBL] [Abstract][Full Text] [Related]
17. Rho GTPases, statins, and nitric oxide.
Rikitake Y; Liao JK
Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
Miida T; Hirayama S; Nakamura Y
J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
